Toumazou has developed an approach to healthcare technology called U+ Life which he says can provide personalised healthcare for early detection, point of care diagnostics and therapeutics to help tackle chronic disease in a consumer-oriented way.
During the lecture, Toumazou will describe example devices including a semiconductor-based artificial pancreas and a lab on chip genetic test.
The 2015 Gabor lecture is free to attend and open to all, but registration is required in advance – book your seat via Eventbrite.
Professor Chris Toumazou is also CEO of DNA Electronics, the developer of semiconductor DNA sequencing technology, and last year he was awarded the UK Institution of Engineering and Technology (IET)’s highest honour, the 2014 Faraday Medal for his pioneering work in the invention of semiconductor DNA sequencing and the potential impact it can have on healthcare.
A feature of the technology is that being semiconductor-based, unlike optical technologies, it can be scaled down enabling DNA sequencing to be performed on a device the size of a USB stick.
In June last year the technology was also recognised by the European Patent Office (EPO) when he was awarded the prestigious 2014 European Inventor of the Year Award for Research.